Analysis of OTC and Prescribed Drugs Working Against COVID-19 Symptoms in the Context of Humans and Surrounding: A Brief Report on Medications Taken by Patients

Kajal      Nagpal; Ashwani      Dhingra; Uditi      Handa; Geeta      Deswal; Priyanka      Kriplani; Kumar      Guarve; Anuj      Malik; Fatimah      Jan; Abhilasha      Dubey

Abstract

Background: Coronaviruses are the genetic series of RNA viruses that infect both organisms mammals and birds. Different varieties of illnesses shown in humans as well as in birds are the most common causes ranging from minor to fatal. Common colds which are included in mild and SARS, MERS, and COVID-19 are caused by fatal. After cell entry, the release of RNA into the cytoplasm occurs, which translates viral proteins followed by processed replication.

Objective: The survey was based on a comparison study between the purchase of OTC and prescribed drugs for COVID-19 symptoms, including the volume of pharmacies from different zones of Yamunanagar district, Haryana.

Methods: The analytical survey involves the different zones of Yamunanagar the pharmacist used in this report. The numerical data is gathered in a methodical investigation which leads to quantitative research. The data investigation was performed by using Statistical Package for Social Sciences (SPSS) version 20.

Results: The north zone area mostly suffered from the COVID-19 pandemic condition from January 2021 to June 2021 in Yamunanagar and found that most of the OTC drugs purchased by consumers were paracetamol (PCM) and Prescribed drugs (HQCS + Azithromycin) by the public regarding covid-19 symptoms.

Conclusion: The outcome of this case report reveals that no statistically significant difference exists between the population parameter and sample statistics while the comparison retained the null hypothesis in different zones of Yamunanagar (Haryana), India including the volume of pharmacy and drug category.

Keywords: Coronavirus, mechanism of viral replication, OTC drugs, prescribed drugs, statistical data, drug interaction.

Graphical Abstract

[1]
Gorbalenya, A.E.; Baker, S.C.; Baric, R.S. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol.,  2020, 5(4), 536-544.
 [http://dx.doi.org/10.1038/s41564-020-0695-z] [PMID:  32123347]

[2]
Gorbalenya, A.E.; Lauber, C. Taxonomy of Viruses; Biomedical sciences; Elsevier, 2019, pp. 1-17.

[3]
Wu, A.; Peng, Y.; Huang, B. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe,  2020, 27(3), 325-328.
 [http://dx.doi.org/10.1016/j.chom.2020.02.001] [PMID:  32035028]

[4]
Fan, Y.; Zhao, K.; Shi, Z.L.; Zhou, P. Bat coronaviruses in China. Viruses,  2019, 11(3), 210.
 [http://dx.doi.org/10.3390/v11030210] [PMID:  30832341]

[5]
Cherry, J.; Demmler Harrison, G.J.; Kaplan, S.L.; Steinbach, W.J.; Hotez, P.J. Coronavirus-19, feigin and cherry’s textbook of pediatric infectious diseases. In: Elsevier health sciences; , 2017; p. 6615.

[6]
Woo, P.C.Y.; Huang, Y.; Lau, S.K.P.; Yuen, K.Y. Coronavirus genomics and bioinformatics analysis. Viruses,  2010, 2(8), 1804-1820.
 [http://dx.doi.org/10.3390/v2081803] [PMID:  21994708]

[7]
Wu, C.; Liu, Y.; Yang, Y. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B,  2020, 10(5), 766-788.
 [http://dx.doi.org/10.1016/j.apsb.2020.02.008] [PMID:  32292689]

[8]
Symptoms of COVID-19.  Available from:
          https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html

[9]
Kreye, J.; Reincke, S.M.; Kornau, H.C.; Sanchez-Sendin, E.; Corman, V.M.; Liu, H. A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model. bioRxiv,  2020, 2020

[10]
Millet, J.K.; Whittaker, G.R. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc. Natl. Acad. Sci. USA,  2014, 111(42), 15214-15219.
 [http://dx.doi.org/10.1073/pnas.1407087111] [PMID:  25288733]

[11]
Kuba, K.; Imai, Y.; Ohto-Nakanishi, T.; Penninger, J.M. Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol. Ther.,  2010, 128(1), 119-128.
 [http://dx.doi.org/10.1016/j.pharmthera.2010.06.003] [PMID:  20599443]

[12]
Chockalingam, A.K.; Hamed, S.; Goodwin, D.G. The effect of oseltamivir on the disease progression of lethal influenza A virus infection: Plasma cytokine and miRNA responses in a mouse model. Dis. Markers,  2016, 2016, 1-12.
 [http://dx.doi.org/10.1155/2016/9296457] [PMID:  27110056]

[13]
Feret, B.M. Handbook of Nonprescription Drugs; American Pharmacists Association, 2015. 

[14]
Afridi, M.I.; Rasool, G.; Tabassum, R.; Shaheen, M. Siddiqullah, Shujauddin M. Prevalence and pattern of self-medication in Karachi: A community survey. Pak. J. Med. Sci.,  2015, 31(5), 1241-1245.
 [http://dx.doi.org/10.12669/pjms.315.8216] [PMID:  26649022]

[15]
Fox, E.R.; Stolbach, A.I.; Mazer-Amirshahi, M. The landscape of prescription drug shortages during the COVID-19 pandemic. J. Med. Toxicol.,  2020, 16(3), 311-313.
 [http://dx.doi.org/10.1007/s13181-020-00786-4] [PMID:  32458230]

[16]
Title of subordinate document.  Available from:
          https://www.ashp.org/Drug-Shortages/Current-Shortages/DrugShortages-List?page=CurrentShortages (Accessed February 2020).

[17]
Wu, R.; Wang, L.; Kuo, H.C.D. An update on current therapeutic drugs treating COVID-19. Curr. Pharmacol. Rep.,  2020, 6(3), 56-70.
 [http://dx.doi.org/10.1007/s40495-020-00216-7] [PMID:  32395418]

[18]
Chan, J.F.W.; Lau, S.K.P.; To, K.K.W.; Cheng, V.C.C.; Woo, P.C.Y.; Yuen, K.Y. Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev.,  2015, 28(2), 465-522.
 [http://dx.doi.org/10.1128/CMR.00102-14] [PMID:  25810418]

[19]
Carter, C.; Notter, J. Pathophysiology of SARS-CoV-2 COVID-19: An Open Access Critical Care Textbook; Elsevier, 2021. 

[20]
World Health Organization. Coronavirus disease (COVID-19): How is it transmitted., 2021. Available from
          https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted

[21]
Yuksel, A.; Karadogan, D.; Gunduz Gurkan, C. Unclear issues regarding COVID-19. Eurasian J. Med.,  2020, 52(2), 191-196.
 [http://dx.doi.org/10.5152/eurasianjmed.2020.20092] [PMID:  32612430]

[22]
 World Health Organization. Advice for the public: Coronavirus disease (COVID-19).  Available from:
          https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public

[23]
World Health Organization Rational use of personal protective equipment for coronavirus disease (COVID-19): Interim guidance., 2019. Available from
          https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages

[24]
Velavan, T.P.; Meyer, C.G. The COVID‐19 epidemic. Trop. Med. Int. Health,  2020, 25(3), 278-280.
 [http://dx.doi.org/10.1111/tmi.13383] [PMID:  32052514]

[25]
Marco, C.; Michael, R.; Aleem, A.; Dulebohn, S.C.; Di Napoli, R. Features, Evaluation, and Treatment of Coronavirus (COVID-19); StatPearls, 2022. 

[26]
Michele, E. Human rhinovirus/enterovirus in pediatric acute respiratory distress syndrome.  J Pediatr Intensi Care,  2020, 09(02), 081-6.

[27]
Jaber, R.M.; Mafrachi, B.; Al-Ani, A.; Shkara, M. Awareness and perception of COVID-19 among the general population: A Middle Eastern survey. PLoS One,  2021, 16(4), e0250461.
 [http://dx.doi.org/10.1371/journal.pone.0250461] [PMID:  33886655]

[28]
Otani, K.; Watanabe, T.; Higashimori, A. A questionnaire-based survey on the impact of the COVID-19 pandemic on gastrointestinal endoscopy in Asia. Digestion,  2022, 103(1), 7-21.
 [http://dx.doi.org/10.1159/000520287] [PMID:  34758472]

[29]
Ju, X.; Zhu, Y.; Wang, Y. A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS Pathog.,  2021, 17(3), e1009439.
 [http://dx.doi.org/10.1371/journal.ppat.1009439] [PMID:  33711082]

[30]
Singh, P.K.; Anvikar, A.; Sinha, A. COVID-19 related knowledge, attitudes, and practices in Indian Population: An online national cross-sectional survey. PLoS One,  2022, 17(3), e0264752.
 [http://dx.doi.org/10.1371/journal.pone.0264752] [PMID:  35239718]

[31]
Aucejo, E.M.; French, J.; Ugalde Araya, M.P.; Zafar, B. The impact of COVID-19 on student experiences and expectations: Evidence from a survey. J. Public Econ.,  2020, 191(3), 104271.
 [http://dx.doi.org/10.1016/j.jpubeco.2020.104271] [PMID:  32873994]

[32]
Biasio, L.R.; Bonaccorsi, G.; Lorini, C.; Pecorelli, S. Assessing COVID-19 vaccine literacy: A preliminary online survey. Hum. Vaccin. Immunother.,  2021, 17(5), 1304-1312.
 [http://dx.doi.org/10.1080/21645515.2020.1829315] [PMID:  33118868]

[33]
Sinha, M; Pande, B; Sinha, R. Impact of COVID-19 lockdown on sleep-wake schedule and associated lifestyle related behavior: A national survey. J Public Health Res,  2020, 9(3), jphr.2020.1826..
 [http://dx.doi.org/10.4081/jphr.2020.1826] [PMID:  32874967]

[34]
Varshney, M.; Parel, J.T.; Raizada, N.; Sarin, S.K. Coronavirus-19, Initial psychological impact of COVID-19 and its correlates in Indian Community, An online survey. PLoS One,  2020, 15(5), 0233874.
 [http://dx.doi.org/10.1371/journal.pone.0233874] [PMID:  32470088]

[35]
Mitchell, E.P. Corona Virus: Global pandemic causing world-wide shutdown. J. Natl. Med. Assoc.,  2020, 112(2), 113-114.
 [http://dx.doi.org/10.1016/j.jnma.2020.03.015] [PMID:  32253007]

[36]
Zhang, C.; Yang, L.; Liu, S. Survey of insomnia and related social psychological factors among medical staff involved with the 2019 novel coronavirus disease outbreak. Front. Psychiatry,  2020, 11, 306.
 [http://dx.doi.org/10.3389/fpsyt.2020.00306] [PMID:  32346373]

[37]
Kulkarni, R.; Chen, W.C.; Lee, Y. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLoS One,  2021, 16(9), e0257191.
 [http://dx.doi.org/10.1371/journal.pone.0257191] [PMID:  34499677]

[38]
Mohamed, N.A.; Solehan, H.M.; Mohd Rani, M.D.; Ithnin, M.; Che Isahak, C.I. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey. PLoS One,  2021, 16(8), e0256110.
 [http://dx.doi.org/10.1371/journal.pone.0256110] [PMID:  34388202]

[39]
Zhu, X.L.; Jiang, H.H.; Jiang, M.H. Questionnaire survey on the current situation and experience in prevention and control measures at urology clinics during the COVID-19 epidemic in China. Front. Public Health,  2021, 9, 670889.
 [http://dx.doi.org/10.3389/fpubh.2021.670889] [PMID:  34490178]

[40]
Hochheimer, C.J.; Sabo, R.T.; Krist, A.H.; Day, T.; Cyrus, J.; Woolf, S.H. Methods for evaluating respondent attrition in web-based surveys. J. Med. Internet Res.,  2016, 18(11), e301.
 [http://dx.doi.org/10.2196/jmir.6342] [PMID:  27876687]

[41]
One-Sample Kolmogorov-Smirnov Test.  Available from:
          https://www.ibm.com/docs/en/spss-statistics/25.0.0?topic=tests-one-sample-kolmogorov-smirnov-test

[42]
Silveira, D.; Prieto-Garcia, J.M.; Boylan, F. COVID-19: Is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? Front. Pharmacol.,  2020, 11, 581840.
 [http://dx.doi.org/10.3389/fphar.2020.581840] [PMID:  33071794]

[43]
Wagner, L.; Cramer, H.; Klose, P. Herbal medicine for cough: A systematic review and meta-analysis. Complement. Med. Res.,  2015, 22(6), 359-368.
 [http://dx.doi.org/10.1159/000442111] [PMID:  26840418]

[44]
Ang, L.; Song, E.; Lee, H.W.; Lee, M.S. Herbal medicine for the treatment of Coronavirus Disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials. J. Clin. Med.,  2020, 9(5), 1583.
 [http://dx.doi.org/10.3390/jcm9051583] [PMID:  32456123]

[45]
Sultana, J.; Cutroneo, P.M.; Crisafulli, S.; Puglisi, G.; Caramori, G.; Trifirò, G. Azithromycin in COVID-19 patients: Pharmacological mechanism, clinical evidence and prescribing guidelines. Drug Saf.,  2020, 43(8), 691-698.
 [http://dx.doi.org/10.1007/s40264-020-00976-7] [PMID:  32696429]

[46]
Noor, A.U.Z.; Kabir, H.; Chowdhury, M.A.A.; Ather, M.F.; Kamrul Hasan, M. An emerging route to antibiotic resistance in South Asia: A correspondence. Ann. Med. Surg.,  2023, 85(2), 335-336.
 [http://dx.doi.org/10.1097/MS9.0000000000000165] [PMID:  36845780]

Cite As